Catalyst: Q4 Financial Results Overview

Catalyst Pharmaceuticals Announces Strong Fourth Quarter Results

Catalyst Pharmaceutical Partners Inc., headquartered in Coral Gables, Florida, revealed a net income of $52.7 million for the fourth quarter.

The company reported earnings of $0.41 per share, while adjusted earnings—accounting for pretax and amortization adjustments—reached $0.68 per share.

These figures surpassed analyst projections, as the consensus from four Zacks Investment Research analysts anticipated earnings of $0.42 per share.

Quarterly revenue totaled $152.6 million, exceeding Wall Street's forecast of $140 million from the same group of analysts.

For the full year, Catalyst Pharmaceuticals achieved a profit of $214.3 million, or $1.68 per share, with annual revenue amounting to $589 million.